DANIELLE WERGE: Open Payments
NPI 1437607793 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,606 in 86 payments from 19 companies in 2025. Trend: 2023 $1,408 · 2024 $5,450 · 2025 $10,606
Speaker / faculty: $4,721Consulting: $3,599Food & beverage: $2,271Travel & lodging: $15
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 24 | $6,493 |
| BioCryst Pharmaceuticals, Inc. | 2 | $2,463 |
| GENZYME CORPORATION | 8 | $415 |
| AstraZeneca Pharmaceuticals LP | 6 | $403 |
| Novartis Pharmaceuticals Corporation | 13 | $183 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| Amgen Inc. | 4 | $101 |
| BioCryst US Sales Co., LLC | 4 | $73 |
| Genentech USA, Inc. | 2 | $47 |
| ADMA BioManufacturing LLC | 4 | $41 |
Products named: DUPIXENT, ORLADEYO, TEZSPIRE, AIRSUPRA, NUCALA, XOLAIR, OPZELURA, INSPIRE.
Industry payments across AZ — which companies pay providers there.
